Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05147792Not ApplicableRecruiting

The CONFORM Pivotal Trial

Role: lead

NCT06049615Not ApplicableNot Yet Recruiting

Conscious Sedation Study

Role: lead

NCT06580275Not ApplicableActive Not Recruiting

The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

Role: lead

NCT03616028Not ApplicableActive Not Recruiting

The CONFORMAL Early Feasibility Study

Role: lead

NCT04193826Not ApplicableCompleted

The Conformal Prague Study

Role: lead

All 5 trials loaded